149 related articles for article (PubMed ID: 36468717)
1. Do generic drugs cause hypersensitivity?
Tetart F; Gonde H; Hervouët C
Eur J Dermatol; 2022 Sep; 32(5):571-576. PubMed ID: 36468717
[TBL] [Abstract][Full Text] [Related]
2. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
Borgheini G
Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
[TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous adverse reaction to drug excipient following brand-to-generic switch of levetiracetam.
Lim JA; Jamil A; Ramli NA; Johar FM; Nor M
Am J Health Syst Pharm; 2024 Jan; 81(3):e69-e72. PubMed ID: 37864830
[TBL] [Abstract][Full Text] [Related]
4. Side Effects of Antihypertensives Induced by Switching to Different Generic Medications: Case Reports.
Wattanapisit A; Lertwatanachai P; Pongsawat T; Wattanapisit S; Thongruch J
Prague Med Rep; 2023; 124(2):172-176. PubMed ID: 37212135
[TBL] [Abstract][Full Text] [Related]
5. Impact of brand or generic labeling on medication effectiveness and side effects.
Faasse K; Martin LR; Grey A; Gamble G; Petrie KJ
Health Psychol; 2016 Feb; 35(2):187-90. PubMed ID: 26462056
[TBL] [Abstract][Full Text] [Related]
6. Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition.
Dickson SR; Kent T
JAMA Netw Open; 2021 Nov; 4(11):e2133451. PubMed ID: 34779844
[TBL] [Abstract][Full Text] [Related]
7. Are generic drugs really inferior medicines?
Moore N; Berdaï D; Bégaud B
Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
[TBL] [Abstract][Full Text] [Related]
8. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
Sacks CA; Lee CC; Kesselheim AS; Avorn J
JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
[TBL] [Abstract][Full Text] [Related]
9. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis.
Leclerc J; Thibault M; Midiani Gonella J; Beaudoin C; Sampalis J
Drugs; 2020 May; 80(7):697-710. PubMed ID: 32279239
[TBL] [Abstract][Full Text] [Related]
10. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of generic drugs.
Andrade C
J Clin Psychiatry; 2015 Sep; 76(9):e1130-1. PubMed ID: 26455677
[TBL] [Abstract][Full Text] [Related]
12. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
Dusetzina SB; Sarpatwari A; Carrier MA; Hansen RA; Keating NL; Huskamp HA
JAMA Intern Med; 2021 Dec; 181(12):1605-1611. PubMed ID: 34661600
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to generic drugs with soybean oil.
Dueñas-Laita A; Pineda F; Armentia A
N Engl J Med; 2009 Sep; 361(13):1317-8. PubMed ID: 19776419
[No Abstract] [Full Text] [Related]
14. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
[TBL] [Abstract][Full Text] [Related]
15. Lack of efficacy during the switch from brand to generic allopurinol.
De Vuono A; Scicchitano F; Palleria C; Russo E; De Sarro G; Gallelli L
J Forensic Leg Med; 2013 Jul; 20(5):540-2. PubMed ID: 23756530
[TBL] [Abstract][Full Text] [Related]
16. [A case of autoimmune hepatitis which worsened after switching from a brand name to a generic version of prednisolone].
Kakizaki S; Suzuki H; Ichikawa T; Sato K; Takagi H; Mori M; Yuasa K
Nihon Shokakibyo Gakkai Zasshi; 2009 Oct; 106(10):1488-93. PubMed ID: 19834296
[TBL] [Abstract][Full Text] [Related]
17. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
Izumi T; Hori S; Satoh H; Miki A; Sawada Y
Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
[TBL] [Abstract][Full Text] [Related]
18. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
19. Brand name versus generic warfarin: a systematic review of the literature.
Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
[TBL] [Abstract][Full Text] [Related]
20. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
Rostron A
Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
